CAS 313516-66-4
:2-Chlor-5-nitro-N-4-pyridinylbenzamid
- 2-Chloro-5-nitro-N-4-pyridinylbenzamide
- 2-chloro-5-nitro-N-pyridin-4-ylbenzamide
- Benzamide, 2-chloro-5-nitro-N-4-pyridinyl-
- T-0070907
- T0070907
T0070907
CAS:Formel:C12H8ClN3O3Reinheit:(HPLC) ≥ 99.0%Farbe und Form:White solidMolekulargewicht:277.66N1-(4-pyridyl)-2-chloro-5-nitrobenzamide
CAS:N1-(4-pyridyl)-2-chloro-5-nitrobenzamideFormel:C12H8ClN3O3Reinheit:98%Farbe und Form: pale yellow solidMolekulargewicht:277.66322g/molT 0070907
CAS:Formel:C12H8ClN3O3Reinheit:>95.0%(T)(HPLC)Farbe und Form:White to Light yellow to Light orange powder to crystalMolekulargewicht:277.66T0070907
CAS:T0070907(IC50=1 nM) , an effective and specific PPARγ inhibitor, with the >800-fold selectivity over PPARα and PPARδ.
Formel:C12H8ClN3O3Reinheit:98.25% - 99.98%Farbe und Form:SolidMolekulargewicht:277.662-Chloro-5-nitro-N-4-pyridinylbenzamide
CAS:Kontrolliertes ProduktApplications A cell-permeable chloro-nitro-benzamido compound that acts as a potent, specific, irreversible, and high-affinity antagonist of PPARγ with a Ki of 1 nM. Displays >800-fold greater selectivity for PPARγ over PPARα and PPARδ (Ki = 0.85 µM and 1.8 µM, respectively). Blocks hormone- and agonist-induced adipogenesis in 3T3-L1 cells. It suppresses interactions between PPARγ and coactivator-derived peptides, while promotes the recruitment of corepressor-derived peptides. Shown to modulate the interaction of PPARγ2 with the cofactor proteins through covalent binding to Cys313 in its ligand-binding domain.
References Lee, G., et al: J. Biol. Chem., 277, 19649 (2003), Schaefer, K.L., et al: Cancer Res., 65, 2251 (2005), Masuda, T., et al.: Clin. Cancer Res., 11, 4012 (2005), Raikwar, H.P., et al.: J. Neuroimmunol., 167, 99 (2005)Formel:C12H8ClN3O3Farbe und Form:NeatMolekulargewicht:277.66







